Table 4. Genetic model analyses of the association between SNPs in ACPY2 and the risk of liver cancer.

SNP-ID	Dominant			Recessive			Additive
	OR	95% CI	P	OR	95% CI	P	OR	95% CI	P
rs6713088	1.32	1.01–1.74	0.043	1.29	0.92–1.81	0.138	1.23	1.02–1.48	0.028
rs12621038	1.22	0.93–1.61	0.158	0.93	0.67–1.28	0.646	1.06	0.80–1.28	0.499
rs1682111	0.68	0.53–0.88	0.003	0.73	0.47–1.14	0.168	0.75	0.61–0.91	0.004
rs843752	1.21	0.94–1.56	0.135	1.03	0.65–1.65	0.886	1.13	0.93–1.38	0.218
rs10439478	1.23	0.94–1.61	0.130	1.17	0.84–1.64	0.351	1.15	0.96–1.38	0.125
rs17045754	1.28	0.97–1.67	0.077	1.27	0.59–2.74	0.536	1.24	0.97–1.57	0.080
rs843720	0.81	0.63–1.05	0.109	0.70	0.45–1.08	0.103	0.82	0.68–1.00	0.049
rs843645	1.32	1.02–1.70	0.033	0.83	0.50–1.37	0.471	1.16	0.94–1.42	0.158
rs11125529	1.20	0.91–1.57	0.197	1.10	0.49–2.45	0.818	1.16	0.91–1.48	0.226
rs12615793	1.18	0.90–1.54	0.224	1.15	0.53–2.45	0.728	1.15	0.91–1.46	0.238
rs843711	1.27	0.96–1.68	0.095	1.50	1.11–2.03	0.009	1.26	1.06–1.51	0.010
rs11896604	1.29	0.99–1.68	0.061	0.98	0.51–1.89	0.960	1.20	0.96–1.50	0.115
rs843706	1.28	0.96–1.69	0.090	1.49	1.10–2.02	0.009	1.26	1.06–1.51	0.010

P-values were calculated using the Wald test with adjustment for age and gender.

P < 0.05 indicates statistical significance.